Sponsor · clinical trials

Seoul National University Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our South Korea register with Seoul National University Hospital as lead sponsor. Synced 15 Nov 2026

201Current trials

127Recruiting now

67Drugs in these trials

1Trial register

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 15 Nov 2026 · Editorial standards

At a glance

Seoul National University Hospital is the lead sponsor of 201 current clinical trials in our South Korea register. 127 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Propofol, Remifentanil and Crystalloid solutions. The most-studied condition is Breast Cancer.

ClinicalTrials.gov trials by status

Recruiting12763%
Not yet open3015%
Active, closed3517%
By invitation94%

Trials by phase

Not applicable8643%
Observational7035%
Phase 4178%
Phase 2178%
Phase 352%
Phase 1/231%
Phase 2/321%
Phase 110%

Clinical trials sponsored by Seoul National University Hospital

201 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism NCT07027254 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma	Not applicable	Recruiting	2025-06	South Korea
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation NCT05996159 · ClinicalTrials.gov ↗ · Paroxysmal Atrial Fibrillation	Not applicable	Recruiting	2023-11	South Korea
Ate-Bev Early Response Prediction Model in Advanced HCC NCT05763277 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma, Atezolizumab-bevacizumab, Response Evaluation	Observational	Recruiting	2022-07	South Korea
Double Unit Cord Blood Transplant in Hematologic Malignancies. NCT06712108 · ClinicalTrials.gov ↗ · Adult Double Unit Cord Blood Transplant	Observational	Recruiting	2023-12	South Korea
Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation NCT06216769 · ClinicalTrials.gov ↗ · Atrial Fibrillation Drug: Rivaroxaban	Not applicable	Recruiting	2024-02	South Korea
Streamlining Radioembolization for Small HCC NCT06979219 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC)	Observational	Recruiting	2025-06	South Korea
Evaluating Length and Depth Estimation Accuracy of Laypersons and Health-Care Providers NCT06552299 · ClinicalTrials.gov ↗ · Cardiopulmonary Resuscitation	Not applicable	Recruiting	2024-08	South Korea
Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea NCT06928818 · ClinicalTrials.gov ↗ · Cancer of Breast, Trastuzumab Emtansine, Trastuzumab Deruxtecan	Observational	Recruiting	2025-02	South Korea
Determinants of Rescue Ventilation Requirement in Airway Surgery Under General Anesthesia With THRIVE NCT06925282 · ClinicalTrials.gov ↗ · Subglottic Stenosis (SGS)	Observational	Recruiting	2025-04	South Korea
EBD RCT Trial in Living Donor Liver Transplantation NCT04622540 · ClinicalTrials.gov ↗ · Liver Transplantation, Liver Transplant; Complications, Bile Stricture	Not applicable	Recruiting	2020-12	South Korea
Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function NCT04643106 · ClinicalTrials.gov ↗ · Benign Ovarian Cyst	Not applicable	Recruiting	2021-02	South Korea
Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia NCT07675850 · ClinicalTrials.gov ↗ · Remimazolam, Pharmacokinetics and Pharmacodynamics	Phase 4	Recruiting	2026-07	South Korea
Scout Dose of Resin Microspheres NCT07476651 · ClinicalTrials.gov ↗ · Radioembolization, Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (ICC)	Not applicable	Recruiting	2026-04	South Korea
Prevention of Delirium in ICU Using Multimodal Interventions NCT05950958 · ClinicalTrials.gov ↗ · Intensive Care Unit Delirium	Not applicable	Recruiting	2022-08	South Korea
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) NCT05845489 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Phase 4	Recruiting	2023-03	South Korea
Agentic AI Personalized Dietary Management Study NCT07638241 · ClinicalTrials.gov ↗ · Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk	Not applicable	Recruiting	2026-06	South Korea
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) NCT05534087 · ClinicalTrials.gov ↗ · Colon Cancer Drug: Folfox	Phase 3	Recruiting	2022-12	South Korea
Cohort Study for Gastric MALT Lymphoma NCT06454149 · ClinicalTrials.gov ↗ · Gastric MALT Lymphoma	Observational	Recruiting	2024-06	South Korea
The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery NCT06710405 · ClinicalTrials.gov ↗ · Pain Management After Surgery Drug: Lidocaine	Phase 4	Recruiting	2024-12	South Korea
Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section NCT06479122 · ClinicalTrials.gov ↗ · Cesarean Section, Postoperative Pain Drug: Acetaminophen	Phase 4	Recruiting	2024-10	South Korea
Severe Sepsis and Septic Shock Registry NCT02936232 · ClinicalTrials.gov ↗ · Sepsis	Observational	Recruiting	2014-08	South Korea
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease NCT05250557 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Observational	Recruiting	2021-08	South Korea
Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma NCT06178198 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma	Phase 2	Recruiting	2023-11	South Korea
EOI Block for Laparoscopic Gastrostomy NCT07119346 · ClinicalTrials.gov ↗ · Gastrostomy	Not applicable	Recruiting	2025-08	South Korea
Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair NCT07806006 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Abdominal, Intraoperative Hypotension Drugs: Propofol, Remimazolam Besylate	Phase 4	Recruiting	2026-10	South Korea
Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations NCT02060695 · ClinicalTrials.gov ↗ · Parkinson Disease	Observational	Recruiting	2012-09	South Korea
Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children NCT07509359 · ClinicalTrials.gov ↗ · Vascular Access Device Complications	Not applicable	Recruiting	2026-04	South Korea
Patient-controlled Remimazolam Sedation Under Spinal Anesthesia NCT07661810 · ClinicalTrials.gov ↗ · Hip Arthroplasty, Spinal Anesthesia, Remimazolam	Not applicable	Recruiting	2026-10	South Korea
The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma NCT05702944 · ClinicalTrials.gov ↗ · Pheochromocytoma, Paraganglioma, Adrenalectomy; Status	Phase 4	Recruiting	2023-01	South Korea
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment NCT06618638 · ClinicalTrials.gov ↗ · ADPKD (autosomal Dominant Polycystic Kidney Disease)	Not applicable	Recruiting	2024-10	South Korea
Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation NCT06699342 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2025-01	South Korea
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients NCT05993390 · ClinicalTrials.gov ↗ · Neuromuscular Blockade, Critical Illness, Neurologic Findings Drugs: Neostigmine, Sugammadex	Not applicable	Recruiting	2024-01	South Korea
Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy NCT05149625 · ClinicalTrials.gov ↗ · Diabetes Mellitus	Not applicable	Recruiting	2022-11	South Korea
Analgesia Nociception Index in Orthognathic Surgery NCT06205355 · ClinicalTrials.gov ↗ · Postoperative Pain	Not applicable	Recruiting	2024-01	South Korea
Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications NCT07410988 · ClinicalTrials.gov ↗ · Cardiac Surgery Drug: Crystalloid solutions	Phase 4	Recruiting	2026-06	South Korea
Prognosis of Paroxysmal Kinesigenic Choreoathetosis in Korea NCT04023656 · ClinicalTrials.gov ↗ · Paroxysmal Kinesigenic Choreoathetosis	Observational	Recruiting	2016-11	South Korea
Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients NCT07609186 · ClinicalTrials.gov ↗ · Cataract, Binaural Beats, Geriatric Anesthesia	Not applicable	Recruiting	2025-08	South Korea
Seoul National University Airway Registry NCT02527486 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease (COPD), Asthma, Asthma With Chronic Obstructive Pulmonary Disease	Observational	Recruiting	2011-09	South Korea
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer NCT06977594 · ClinicalTrials.gov ↗ · Ovarian Cancer, Endometrial Cancer, Cervical Cancer Drug: Paclitaxel and Carboplatin	Not applicable	Recruiting	2025-05	South Korea
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke NCT06649240 · ClinicalTrials.gov ↗ · Ischemic Stroke, Small Vessel Cerebrovascular Disease, Cholesterol, LDL Drugs: Biweekly, Ezetimibe	Not applicable	Recruiting	2024-10	South Korea
Registry for Degenerative Spinal Disease (RDSD) NCT05332249 · ClinicalTrials.gov ↗ · Degeneration Spine, Surgery	Observational	Recruiting	2021-03	South Korea
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy NCT06984952 · ClinicalTrials.gov ↗ · Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer	Not applicable	Recruiting	2025-06	South Korea
Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS NCT05912569 · ClinicalTrials.gov ↗ · DCIS	Not applicable	Recruiting	2023-06	South Korea
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance NCT02971085 · ClinicalTrials.gov ↗ · Prostate Cancer	Observational	Recruiting	2016-12	South Korea
Same-day Radioembolization for Large HCC NCT06944483 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC)	Observational	Recruiting	2025-04	South Korea
Intravenous Dexamethasone With Single-Shot Versus Continuous Brachial Plexus Block for Rebound Pain After Shoulder Surgery NCT07699744 · ClinicalTrials.gov ↗ · Pain, Postoperative, Rebound Pain, Shoulder Injuries Drug: Dexamethasone	Phase 4	Recruiting	2026-08	South Korea
Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data NCT06380049 · ClinicalTrials.gov ↗ · Stroke, Fall	Observational	Recruiting	2024-05	South Korea
Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study) NCT05460975 · ClinicalTrials.gov ↗ · Breast Cancer, Screening	Observational	Recruiting	2022-11	South Korea
A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System NCT07363278 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Observational	Recruiting	2025-12	South Korea
Transition of Care in Pediatric Rare Endocrine Disorders NCT07786142 · ClinicalTrials.gov ↗ · Endocrine Disorder, Rare Disorders	Not applicable	Recruiting	2026-05	South Korea
Evaluation of Mixed Reality Cardiopulmonary Resuscitation Training NCT07363772 · ClinicalTrials.gov ↗ · Cardiopulmonary Resuscitation (CPR), Basic Life Support Training Course, Cardiac Arrest (CA)	Not applicable	Recruiting	2026-02	South Korea
Comprehensive Swallowing Rehabilitation in Patients With MSA NCT04782284 · ClinicalTrials.gov ↗ · Multiple System Atrophy	Not applicable	Recruiting	2021-05	South Korea
Effects of Sufentanil on the Intraoperative Hemodynamics NCT06091904 · ClinicalTrials.gov ↗ · Intraoperative Hypotension Drugs: Remifentanil, Sufentanil	Not applicable	Recruiting	2023-11	South Korea
Case Studies of Patients Who Had Experienced Near Death Experience NCT05544799 · ClinicalTrials.gov ↗ · Near Death Experience	Observational	Recruiting	2021-01	South Korea
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy NCT06920251 · ClinicalTrials.gov ↗ · Relapsed Refractory Multiple Myeloma (RRMM) Drugs: Elranatamab, Letermovir	Phase 2	Recruiting	2025-09	South Korea
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients NCT04932928 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2, Lifestyle Risk Reduction	Not applicable	Recruiting	2021-03	South Korea
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Patients With Complex Congenital Heart Disease NCT07572435 · ClinicalTrials.gov ↗ · Complex Congenital Heart Disease	Not applicable	Recruiting	2026-05	South Korea
Extremely Preterm Respiratory Outcome Cohort NCT06726226 · ClinicalTrials.gov ↗ · Infant, Premature, Respiratory Disease	Observational	Recruiting	2022-06	South Korea
Thrombus Analysis of Ischemic Stroke NCT07043413 · ClinicalTrials.gov ↗ · Cerebral Infarction	Observational	Recruiting	2022-01	South Korea
Intestinal Metaplasia Cohort for Gastric Cancer Prediction NCT06075199 · ClinicalTrials.gov ↗ · Intestinal Metaplasia of Gastric Mucosa	Observational	Recruiting	2023-09	South Korea
Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease NCT06794294 · ClinicalTrials.gov ↗ · Rotator Cuff Disease	Phase 1/2	Recruiting	2025-01	South Korea
Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria NCT06773845 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC), Radioembolization	Phase 2	Recruiting	2025-03	South Korea
RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy NCT06930092 · ClinicalTrials.gov ↗ · Ischemic Cardiomyopathy	Not applicable	Recruiting	2025-08	South Korea
REBOA in Nontraumatic OHCA NCT06031623 · ClinicalTrials.gov ↗ · Cardiopulmonary Arrest	Not applicable	Recruiting	2023-10	South Korea
Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients NCT07895394 · ClinicalTrials.gov ↗ · Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant Recipient	Phase 4	Recruiting	2026-10	South Korea
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More NCT06622603 · Gout, Uric Acid Drug: Febuxostat	Phase 4	Recruiting	2025-09	South Korea
EOI Block in Otoplasty With Rib Cartilage Graft NCT07262944 · ClinicalTrials.gov ↗ · Postoperative Pain, Acute	Not applicable	Recruiting	2026-12	South Korea
Repository for Sepsis and Postresuscitation Samples NCT01670383 · ClinicalTrials.gov ↗ · Cardiac Arrest, Sepsis	Observational	Recruiting	2006-07	South Korea
Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) NCT05505357 · ClinicalTrials.gov ↗ · Breast Cancer Invasive	Not applicable	Recruiting	2022-09	South Korea
The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery NCT06710353 · ClinicalTrials.gov ↗ · Acute Kidney Injury, Pediatric Cardiac Surgery Drugs: Albumin, Crystalloid solutions	Not applicable	Recruiting	2025-01	South Korea
No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy NCT06704945 · ClinicalTrials.gov ↗ · Breast Cancer, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy	Phase 3	Recruiting	2025-06	South Korea
Korean College of Rheumatology Biologics and Targeted Therapy Registry NCT01965132 · ClinicalTrials.gov ↗ · Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis Drugs: Abatacept, Adalimumab, Baricitinib	Observational	Recruiting	2012-12	South Korea
Effectiveness of Intraoperative Neuromonitoring of External Branch of Superior Laryngeal Nerve in Thyroid Surgery NCT06002984 · Laryngeal Nerve Injuries, Thyroidectomy, Voice Change	Not applicable	Recruiting	2023-11	South Korea
Prospective Cohort Study of Rapid Response Team NCT02986581 · ClinicalTrials.gov ↗ · Hospital Medical Emergency Team, Medicine, Emergency, Hospital Rapid Response Team	Observational	Recruiting	2016-11	South Korea
KNOW-CKD Cohort, Phase II Study NCT03929900 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases	Observational	Recruiting	2019-05	South Korea
SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer) NCT05636384 · ClinicalTrials.gov ↗ · Malignant Neoplasm, Home Care Services, Quality of LIfe	Not applicable	Recruiting	2022-07	South Korea
Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis NCT06166576 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma	Phase 2	Recruiting	2023-11	South Korea
Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty NCT07634523 · ClinicalTrials.gov ↗ · Sarcopenia, Total Knee Arthroplasty	Phase 4	Recruiting	2025-02	South Korea
The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia NCT05599880 · ClinicalTrials.gov ↗ · Relapsed/Refractory Immune Thrombocytopenia Drug: Bortezomib	Phase 2	Recruiting	2023-07	South Korea
Can a Pain Monitor Predict When Postoperative Intensive Care Unit Patients Are Ready to Breathe on Their Own? A Pilot Study NCT07771101 · ClinicalTrials.gov ↗ · Ventilator Weaning, Airway Extubation, Respiration, Artificial	Observational	Recruiting	2026-08	South Korea
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation NCT06247501 · ClinicalTrials.gov ↗ · Very High Risk Acute Lymphoblastic Leukemia, CD19 CAR-T Therapy	Phase 2	Recruiting	2024-01	South Korea
Streamlining Radioembolization for CCC and Metastatic Liver Cancer NCT07043387 · ClinicalTrials.gov ↗ · Metastatic Colorectal Carcinoma (mCRC), Metastatic Liver Cancer, Cholangiocarcinoma	Observational	Recruiting	2025-06	South Korea
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) NCT05254197 · ClinicalTrials.gov ↗ · Brain Tumor, Primary, Meningioma, Schwannoma	Observational	Recruiting	2001-01	South Korea
Venetoclax and Decitabine in R/R T-ALL NCT06712121 · ClinicalTrials.gov ↗ · T Lymphoblastic Leukemia/Lymphoma Drugs: Decitabine, Venetoclax	Phase 2	Recruiting	2025-01	South Korea
Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease NCT07374679 · ClinicalTrials.gov ↗ · Rotator Cuff Disease	Observational	Recruiting	2026-01	South Korea
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer NCT05431530 · ClinicalTrials.gov ↗ · Ovarian Cancer, Low Anterior Resection Syndrome, Quality of Life	Observational	Recruiting	2022-06	South Korea
Nostril Side on Epistaxis NCT06605989 · ClinicalTrials.gov ↗ · Nasotracheal Intubation	Not applicable	Recruiting	2024-09	South Korea
Prognosis and Risk Factors for Acute Kidney Injury NCT06898944 · ClinicalTrials.gov ↗ · Acute Kidney Injury	Observational	Recruiting	2022-08	South Korea
5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS) NCT05577845 · ClinicalTrials.gov ↗ · LARS - Low Anterior Resection Syndrome Drug: Ramosetron	Not applicable	Recruiting	2023-03	South Korea
Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION) NCT04370496 · ClinicalTrials.gov ↗ · Cervical Cancer, Cervical Cancer Stage IB1, Minimally Invasive Surgery	Not applicable	Recruiting	2020-07	South Korea
The Postoperative Radiotherapy in N1 Breast Cancer Patients NCT05440149 · ClinicalTrials.gov ↗ · Radiotherapy, Breast Cancer	Phase 3	Recruiting	2022-08	South Korea
Clinical Characteristics of Patients With Sleep Apnea in Korea NCT04186078 · ClinicalTrials.gov ↗ · Sleep Apnea Syndromes	Observational	Recruiting	2019-11	South Korea
Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery NCT07304947 · ClinicalTrials.gov ↗ · Moyamoya Disease	Not applicable	Recruiting	2025-12	South Korea
Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency NCT04892693 · ClinicalTrials.gov ↗ · Advanced Breast Cancer Drug: Talazoparib	Phase 2	Recruiting	2021-05	South Korea
Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies NCT06426992 · ClinicalTrials.gov ↗ · Liver Malignant Tumors	Not applicable	Recruiting	2024-04	South Korea
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887 · ClinicalTrials.gov ↗ · Glomerular Disease, Minimal Change Disease, IgA Nephropathy	Observational	Recruiting	2019-05	South Korea
CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus NCT07855302 · ClinicalTrials.gov ↗ · Childhood-Onset Systemic Lupus Erythematosus, Refractory SLE, CD19 CAR-T Cell Therapy	Phase 1	Recruiting	2026-09	South Korea
Remimazolam Consumption: TCI vs. Manual Infusion NCT07377695 · ClinicalTrials.gov ↗ · Moyamoya Disease	Not applicable	Recruiting	2026-02	South Korea
Prospective CT Assessment After DCB NCT07373145 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Observational	Recruiting	2025-08	South Korea
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies NCT07014319 · ClinicalTrials.gov ↗ · Cytomegalovirus (CMV) Drug: Maribavir	Phase 2	Recruiting	2025-11	South Korea

Showing the 100 most recently updated of 201 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Seoul National University Hospital trials

67 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

+ 27 more in the trial list above.

Conditions in Seoul National University Hospital trials

317 conditions

Breast Cancer7 Hepatocellular Carcinoma5 Hepatocellular Carcinoma (HCC)5 Coronary Artery Disease5Radioembolization3Atrial Fibrillation (AF)3Neuromuscular Blockade3Low Anterior Resection Syndrome3Advanced Breast Cancer3 Primary Aldosteronism2Pheochromocytoma2Atrial Fibrillation2Remimazolam2Postoperative Pain2 Sepsis2 Ischemic Stroke2Intraoperative Hypotension2Critical Illness2Nonsuicidal Self-Injury2Cardiac Surgery2Geriatric Anesthesia2Metabolic Dysfunction-Associated Steatotic Liver Disease2 Asthma2 Ovarian Cancer2

By trial register

Register	Trials	Recruiting
Clinical trials in South Korea	201	127

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Breast Cancer

Sponsor	Trials
Fudan University	50
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	21
AstraZeneca	18
Second Affiliated Hospital, Zhejiang University, School of Medicine	18
University Health Network, Toronto	16
Institut du Cancer de Montpellier - Val d'Aurelle	16
Sunnybrook Health Sciences Centre	15
Shengjing Hospital	15
European Institute of Oncology	14
Pfizer	12

Sponsors with the most current trials registered for this condition.

Questions about Seoul National University Hospital trials

How many clinical trials does Seoul National University Hospital sponsor?

Seoul National University Hospital is the lead sponsor of 201 current trials on ClinicalTrials.gov in our South Korea register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are Seoul National University Hospital trials recruiting?

Yes. 127 of its 201 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Seoul National University Hospital testing?

Its current trials name 67 drugs and biologicals as interventions. The most frequent are Propofol (3), Remifentanil (3), Crystalloid solutions (2), Naltrexone (2) and Olaparib (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.